斑流体溶解与患有恶性斑溢液的患者的生存率改善有关
Christina R MacRosty1,2, Amber Wright1, Agathe Ceppe3
1Section of Interventional Pulmonology and Pulmonary Oncology, Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
在恶性多流中,多液的分离显著改善了生存率. 这一发现表明液体分离可能表明有效的潜在癌症治疗.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 内部医学 内部医学
背景情况:
- 恶性流 (MPE) 预后不佳.
- 现有的MPE风险分层模型没有纳入膜液分辨率.
- 对于MPE解决方案的预后意义仍然未被评估.
研究的目的:
- 调查MPE患者的肺液分离和存活率之间的关联.
- 为了确定与MPE中膜液分辨率相关的因素.
主要方法:
- 对123名被诊断患有MPE的患者 (2013-2017年) 的回顾性审查.
- 分析患者的人口统计数据,腹腔液和血清成分以及治疗数据.
- 考克斯回归分析以评估生存相关性.
主要成果:
- 在MPE患者中,平均存活时间为4.8个月.
- 胸腔液分离显著与改善的生存率有关,独立于其他因素.
- 与流体分辨率相关的因素包括多液蛋白质升高,内置多导管放置以及向/激素治疗.
结论:
- 恶性肺液的消失与MPE患者的生存益处有关.
- 胸腔液分辨率可以作为一种替代标记,用于有效治疗转移性癌症.
- 需要进一步的研究,以了解恶性肺空间中流体分离和瘤免疫相互作用的机制.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
05:44Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
相关概念视频
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleura of the Lungs
Pleural Disorders: Types and Brief Description
Pneumothorax-II
Clinical Manifestations:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
